Kirurgisk behandling af type 2-diabetes
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Kirurgisk behandling af type 2-diabetes. / Olesen, Stine Chabert; Hansen, Dorte Lindqvist; Almdal, Thomas; Bendtsen, Flemming; Nordgaard, Inge; Hvolris, Lisbeth Edvardsen; Holst, Jens J; Naver, Lars; Madsbad, Sten.
In: Ugeskrift for læger, Vol. 171, No. 8, 2009, p. 615-7.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Kirurgisk behandling af type 2-diabetes
AU - Olesen, Stine Chabert
AU - Hansen, Dorte Lindqvist
AU - Almdal, Thomas
AU - Bendtsen, Flemming
AU - Nordgaard, Inge
AU - Hvolris, Lisbeth Edvardsen
AU - Holst, Jens J
AU - Naver, Lars
AU - Madsbad, Sten
N1 - Keywords: Anastomosis, Roux-en-Y; Bariatric Surgery; Diabetes Mellitus, Type 2; Gastric Bypass; Gastroplasty; Glucose; Humans; Remission Induction
PY - 2009
Y1 - 2009
N2 - The resolution of diabetes after gastric bypass is already observed during the first days after the operation, while the control of diabetes after gastric banding occurs after weight loss. Other mechanisms than weight loss must therefore explain the improved glucose tolerance. Focus has been on appetite-regulating gut hormone, particularly peptide YY and glucagon-like peptide-1. Nevertheless, other unknown hormones or mechanisms may be involved in the dramatic changes in the glucose metabolism. Development of new drugs and treatments based on the endocrine changes observed after bariatric surgery with the aim of curing type 2-diabetes are warranted. Udgivelsesdato: 2009-Feb-16
AB - The resolution of diabetes after gastric bypass is already observed during the first days after the operation, while the control of diabetes after gastric banding occurs after weight loss. Other mechanisms than weight loss must therefore explain the improved glucose tolerance. Focus has been on appetite-regulating gut hormone, particularly peptide YY and glucagon-like peptide-1. Nevertheless, other unknown hormones or mechanisms may be involved in the dramatic changes in the glucose metabolism. Development of new drugs and treatments based on the endocrine changes observed after bariatric surgery with the aim of curing type 2-diabetes are warranted. Udgivelsesdato: 2009-Feb-16
M3 - Tidsskriftartikel
C2 - 19284908
VL - 171
SP - 615
EP - 617
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 8
ER -
ID: 18700799